Ustekinumab Starts A Phase II Clinical Trial Called USTEKID

Type 1 & LADA T1 Research
1

Ustekinumab is starting a clinical trial in the UK:

2 Likes
2

Interesting study.

The no-publish status if the other two studies is worrisome. I’ll keep my fingers crossed.

1 Like